Qinsong Sheng

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Targeting LIG1 to overcome oxaliplatin resistance by inducing PANoptosis in colorectal cancer.

Targeting LIG1 to overcome oxaliplatin resistance by inducing PANoptosis in colorectal cancer.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: March 06, 2026

β-mangostin triggers ER stress-mediated mitochondrial dysfunction to induce apoptosis in colorectal cancer.

β-mangostin triggers ER stress-mediated mitochondrial dysfunction to induce apoptosis in colorectal cancer.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: January 28, 2026

Tetrahydromagnolol targets TRIM38 to mediate PANoptosis in cancer cells and has the potential for synergistic cancer therapy.

Tetrahydromagnolol targets TRIM38 to mediate PANoptosis in cancer cells and has the potential for synergistic cancer therapy.

Journal: Experimental hematology & oncology

Published: July 03, 2025

Honokiol-Magnolol-Baicalin Possesses Synergistic Anticancer Potential and Enhances the Efficacy of Anti-PD-1 Immunotherapy in Colorectal Cancer by Triggering GSDME-Dependent Pyroptosis.

Honokiol-Magnolol-Baicalin Possesses Synergistic Anticancer Potential and Enhances the Efficacy of Anti-PD-1 Immunotherapy in Colorectal Cancer by Triggering GSDME-Dependent Pyroptosis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 17, 2024

Causal relationship between cancer and immune cell traits: A two-sample mendelian randomization study.

Causal relationship between cancer and immune cell traits: A two-sample mendelian randomization study.

Journal: Heliyon

Published: October 03, 2023

Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy.

Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy.

Journal: Frontiers in immunology

Published: June 21, 2022

SARS-CoV-2 Host Receptor ACE2 Protein Expression Atlas in Human Gastrointestinal Tract.

SARS-CoV-2 Host Receptor ACE2 Protein Expression Atlas in Human Gastrointestinal Tract.

Journal: Frontiers in cell and developmental biology

Published: January 28, 2021

Ursolic Acid Regulates Intestinal Microbiota and Inflammatory Cell Infiltration to Prevent Ulcerative Colitis.

Ursolic Acid Regulates Intestinal Microbiota and Inflammatory Cell Infiltration to Prevent Ulcerative Colitis.

Journal: Journal of immunology research

Published: December 09, 2020

Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.

Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy.

Journal: Frontiers in immunology

Published: October 28, 2020

Characteristics of fecal gut microbiota in patients with colorectal cancer at different stages and different sites.

Characteristics of fecal gut microbiota in patients with colorectal cancer at different stages and different sites.

Journal: Oncology letters

Published: November 27, 2018

Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer.

Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer.

Journal: Digestion

Published: June 25, 2018

Nicotinamide adenine dinucleotide replenishment rescues colon degeneration in aged mice.

Nicotinamide adenine dinucleotide replenishment rescues colon degeneration in aged mice.

Journal: Signal transduction and targeted therapy

Published: December 01, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026